At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 107 enrolled
Drug / intervention
Visonac PDT (MAL PDT) +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double Blinded, Prospective, Randomized, Stratified, Placebo-controlled, Multi-center Study of Photodynamic Therapy With VisonacTM Cream in Patients With Moderate to Severe Acne Vulgaris.
In Brief
A Phase 2 clinical trial evaluating Visonac PDT (MAL PDT), Vehicle cream (placebo), and 1 other intervention for Acne Vulgaris. Completed, enrolled 107 participants across 11 sites in 2 countries.
Detailed Summary
The purpose of this trial is to study the efficacy and safety of Visonac PDT in patients from 9 to 35 years old with Aktilite® CL512. Patients was randomized to Visonac or vehicle cream without occlusion and red light(dose: 37J/cm2)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesCanada, United States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 2009
Enrollment StartAug 2009
Primary CompletionMar 2010
TodayJul 2026
First PostedJul 7, 2009
Enrollment StartAug 1, 2009
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.0 years ago
Interventions
Visonac PDT (MAL PDT)drug
Cream application followed by illumination with red light.
Vehicle cream (placebo)drug
Cream application followed by illumination with red light.
PDTprocedure
Photodynamic Therapy - Light dose 37 J/cm2